JCT fluctuates 40.1% in 24 hours: price experiences intense volatility with no clear 24h driving event
Bitget Pulse2026/05/16 10:42Volatility Overview
JCT (Janction) surged rapidly from a low of $0.003286 to a high of $0.004605 over the past 24 hours, before correcting back to the current $0.003300, resulting in an overall amplitude of 40.1%. According to real-time data from platforms such as CoinMarketCap, Yahoo Finance, and KuCoin, 24-hour trading volume remains at the multi-million to ten-million dollar level (some platforms show approximately $5.5 million to $10 million), indicating high market liquidity but unclear direction, with no significant net capital inflow or outflow recorded.
Brief Analysis of the Volatility Cause
- No verifiable direct drivers were found in the past 24 hours, such as official announcements, major partnership news, large on-chain transfers, or abnormal activities from whale addresses.
- Previously (May 13th), JCT experienced a single-day gain of 33% driven by active Binance spot trading, but this event is outside the current 24-hour window and is only referenced here as historical background.
- The current sharp price swings are mainly related to a high-leverage trading environment and overall speculative sentiment in the crypto market, with no single verifiable news or on-chain event as support.
Market Outlook and Perspectives
Discussion in the community and on mainstream platforms shows that investors are cautiously observing JCT's short-term fluctuations. Some analysts point out that the team's token unlock in May (approximately 1.067 billion tokens, accounting for 21% of total supply) may generate potential selling pressure, recommending attention to changes in liquidity and trading volume. Overall market sentiment remains neutral; without new catalysts in the short term, the price may continue to fluctuate within a high volatility range.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
